Aditxt Inc. (ADTX)
NASDAQ: ADTX
· Real-Time Price · USD
1.06
0.04 (3.92%)
At close: Aug 18, 2025, 3:59 PM
1.08
1.89%
Pre-market: Aug 19, 2025, 07:00 AM EDT
3.92% (1D)
| Bid | 1.04 |
| Market Cap | 2.58M |
| Revenue (ttm) | 55.32K |
| Net Income (ttm) | -25.43M |
| EPS (ttm) | -25.94 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.09 |
| Volume | 172,415 |
| Avg. Volume (20D) | 840,629 |
| Open | 1.02 |
| Previous Close | 1.02 |
| Day's Range | 1.00 - 1.08 |
| 52-Week Range | 0.81 - 11700.00 |
| Beta | 1.37 |
About ADTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ADTX
Website n/a
5 months ago
+71.62%
Aditxt shares are trading higher after the company...
Unlock content with
Pro Subscription
5 months ago
-41.2%
Aditxt shares are trading lower after the company announced a 1-for-250 reverse stock split.
2 months ago · businesswire.com
Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of DirectorsMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the appointment...
3 months ago · businesswire.com
Aditxt Announces Termination of Arrangement Agreement With Appili TherapeuticsMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced that it has det...